ARCHIVES

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: Geza Jak Reportedly Picked For Cancer Panel; Supreme Court To Hear Cigarette Label Case

April 12, 1991

FDA Approves Genetic Test For Breast Cancer Patients

January 25, 2008

Stone(y) Silence Didn’t Save His Job; Niamd’s Rall Rumored as Top Choice As New NIH Director

December 20, 1974

Senate committee approves $1.1 billion increase for NIH.

October 1, 2004

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

October 26, 1979

Rauscher Explains Reasons for Treatment Switches

May 9, 1975